drugset

drugset / Trial / NCT00946608

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

NCT00946608 ↗

Phase 1 Completed 30 enrolled Sandoz

RandomizedSingle-groupOpen-labelTreatment

Summary

To demonstrate the relative bioavailability study of Loratadine 10 mg tablets.

Timeline

Start: 2005-06
Primary completion: 2005-08
Completion: 2005-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Loratadine	Small molecule	10 mg	—

Indications